StockData
Nephros Inc logo

Nephros Inc (NEPH) stock

NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3026% below fair value
$3.05−0.26 (-7.85%)

Close on Nov 13, 2026Market cap $33.12MP/E 16.9Yield –

Nephros price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Nephros's price to book ratio was 2.8× on Apr 30, 2024, against 2.6× a year earlier. Over the last 5 years it ranged from 1.0× to 163.7×, with a median of 5.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Apr 30, 20242.8×−1.4
2023Dec 29, 20234.2×+2.3
2022Dec 30, 20221.9×−3.0
2021Dec 31, 20214.9×−4.3
2020Dec 31, 20209.2×−11.6
2019Dec 31, 201920.9×+11.9
2018Dec 31, 20189.0×−83.0
2017Dec 29, 201792.0×+77.2
2016Dec 30, 201614.8×+11.3
2015Dec 31, 20153.5×−95.7
2014Oct 31, 201499.3×+81.7
2013Dec 31, 201317.6×−25.2
2012Dec 31, 201242.8×+39.1
2011Dec 30, 20113.7×–

More Nephros figures

See a number that looks wrong?